UK markets close in 58 minutes

Cartesian Therapeutics, Inc. (RNAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
23.19-0.01 (-0.06%)
As of 10:31AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
26,004
26,004
110,777
85,077
16,597
Operating expenses
Research development
71,839
71,839
72,377
68,736
54,505
Selling general and administrative
40,581
40,581
23,862
20,938
18,913
Total operating expenses
112,420
112,420
96,239
89,674
73,418
Operating income or loss
-86,416
-86,416
14,538
-4,597
-56,821
Interest expense
2,833
2,833
3,031
2,844
1,556
Total other income/expenses net
-149,461
-149,461
23,263
-2,280
-10,499
Income before tax
-238,710
-238,710
34,770
-9,721
-68,876
Income tax expense
-19,000
-19,000
-609
15,966
0
Income from continuing operations
-219,710
-219,710
35,379
-25,687
-68,876
Net income
-219,710
-219,710
35,379
-25,687
-68,876
Net income available to common shareholders
-219,710
-219,710
35,379
-25,687
-68,876
Basic EPS
-0.24
-1.66
0.24
-0.22
-0.68
Diluted EPS
-0.32
-1.66
0.10
-0.22
-0.68
Basic average shares
153,685
155,110
144,759
114,329
101,202
Diluted average shares
153,685
155,110
145,875
114,329
101,202